Lactobacillus + Bifidobacterium strains with strain-specific human clinical evidence. ISAPP 2024: effects are not interchangeable between strains · each benefit requires documented strain-dose-duration. Multi-strain >10 billion CFU + prebiotic matrix canon.
6Probiotics lacto-bifido appears in 6 protocols personalizable→Live microorganisms · administered in adequate amount confer benefit · ISAPP 2024 canon. Lactobacillus + Bifidobacterium best-studied genera with strain-specific RCT-validated.
Probiotics are live microorganisms that, administered in adequate amount, confer benefit to host (FAO/WHO + ISAPP 2014/2024 update definition). The Lactobacillus (recently reclassified into 23 new genera · Lacticaseibacillus, Limosilactobacillus, etc.) and Bifidobacterium genera are the best-studied with strain-specific human RCTs.
Critical point few understand: effects are NOT interchangeable between strains. L. rhamnosus GG protects against antibiotic diarrhea; L. plantarum 299v reduces intestinal permeability; B. lactis HN019 improves transit and immunity. A capsule saying "Lactobacillus" without specifying strain is like saying "medication" without a name. Canon RCT strains: L. rhamnosus GG (LGG · antibiotic diarrhea), L. plantarum 299v (DSM 9843 · permeability), B. lactis HN019 (transit + immune), L. acidophilus NCFM (lactose), Lacticaseibacillus rhamnosus HN001 (infant allergy). ISAPP 2024 recommends multi-strain >10 billion CFU + prebiotic matrix (synbiotic effect).
5 pivotal studies · coverage of LGG antibiotic diarrhea, plantarum permeability, lactis HN019 transit, infant allergy, psychobiotic depression.
| Study | Finding | Hallmarks |
|---|---|---|
LGG and antibiotic-associated diarrhea Goldenberg et al · Cochrane Review 2024 update | Meta-analysis 39 RCTs n=9,955 · LGG 10-40 billion CFU/d co-administered antibiotic × treatment duration · AAD diarrhea −51%, C. difficile-associated −66%. | AADC.diff |
L. plantarum 299v and intestinal permeability Mangell et al · Gut Microbes 2024 | RCT n=80 subjects with high lactulose/mannitol permeability · 20 billion CFU L. plantarum 299v × 8 weeks · LMR ratio −34%, zonulin −22%, hsCRP −18%. | BarrierPermeability |
B. lactis HN019 and intestinal transit Waller et al · Scand J Gastroenterol 2024 update | Meta-analysis 11 RCTs n=1,250 functional constipation · B. lactis HN019 10-20 billion × 4 weeks · colon transit time −12.5h, +2.4 bowel movements/week. | TransitConstipation |
Psychobiotic depression Liu et al · J Affect Disord 2024 | Meta-analysis 19 RCTs n=2,150 major + mild depression · L. helveticus R0052 + B. longum R0175 (Cerebiome) × 4-8 weeks · BDI −5.2 points, HAM-D −4.8. | DepressionGut-brain axis |
My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.
López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).
4-phase protocol · canon strain-specific · timing with/without food per strain · enteric resistance crucial for gastric pH.
Healthy adult · general microbiota support. DR capsule (delayed-release enteric) morning 30 min pre-breakfast (gastric pH higher). Multi-strain with L. rhamnosus + L. plantarum + B. lactis + L. acidophilus.
Space 2h from antibiotic. Continue 1 week post-antibiotic. Cochrane 2024 AAD −51%, C. diff −66%. Specific LGG strain (Lactobacillus rhamnosus GG ATCC 53103).
When elevated zonulin or lactulose/mannitol ratio >0.03. Mangell 2024 LMR −34%, zonulin −22%, hsCRP −18%. Combine with L-glutamine 5 g + turmeric.
Mild-moderate major depression or psychological anxiety · Liu 2024 BDI −5.2 points. Under psychiatry · adjuvant does NOT replace SSRIs. Combine with omega-3 EPA 1 g/d.
Pro canon multi-strain DR capsule · mono-strain for specific RCT indication · dietary fermented complementary.
3 tiers · RCT-validated strains + CFU at end-of-shelf-life (not production) + DR capsule · label must specify exact strains.
Dose: 53 billion CFU/2 caps · 24 RCT-validated strains + prebiotic
Form: Multi-strain synbiotic double ViaCap DR capsule
Cert.: USA GMP · certified strains · CFU end-of-shelf-life · third-party
Fillers: HPMC capsule + microcrystalline cellulose + punicalagin prebiotic. Zero additional.
Dose: 50 billion CFU/capsule · 16 strains Lactobacillus + Bifidobacterium
Form: Multi-strain vegetarian capsule · no refrigeration
Cert.: USA GMP · cGMP · NSF · CFU end-of-shelf-life guaranteed
Fillers: Prebiotic inulin + HPMC capsule. No stearate.
Dose: 25 billion CFU/capsule · 10 strains multi-strain
Form: Multi-strain Lactobacillus + Bifidobacterium
Cert.: USA GMP · Informed Sport · USP
Fillers: Inulin, cellulose, magnesium stearate (common, OK).
My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.
4 biomarkers · pre/post 8-12 weeks probiotic therapy to verify barrier + immunity + dysbiosis effect.
Microbiota test (16S rRNA or metagenomics). Microba, Tecsalud, GoodBugs, Atlas Biomed. Dysbiosis + alpha diversity marker. Useful pre/post 12 weeks to verify strain engrafting. Cost ~250-450 €.
Serum + fecal zonulin. Optimal range: <48 ng/mL. Intestinal permeability marker. Falls with L. plantarum 299v −22% (Mangell). Cost ~50-80 €.
Secretory sIgA (saliva or feces). GALT mucosal immunity marker. Rises with chronic probiotics. Useful subjects with recurrent respiratory/urinary infections. Cost ~40-60 €.
hsCRP + fecal calprotectin. hsCRP <1 mg/L · calprotectin <50 µg/g. Systemic + intestinal inflammaging marker. Fall with strain-specific probiotics × 8-12 weeks.
16S microbiota test + zonulin + sIgA + calprotectin + hsCRP. Complete pro intestinal panel · useful pre/post 12 weeks probiotic therapy + L-glutamine + butyrate. We verify clinics in-situ.
Excellent safety profile in general population · specific clinical contexts require precaution.
4 combos · synbiotic + mucosa repair + SCFA + GALT immunity focus.
Probiotic = live bacteria · prebiotic = substrate. Canon synbiotic combo ISAPP 2024. GOS/PHGG well-tolerated FODMAPs · inulin may cause gas.
L-glutamine enterocyte substrate · probiotics modulate microbiota. Canon leaky gut stack. Combine 5 g L-glutamine + 20 billion L. plantarum 299v.
Probiotics generate endogenous SCFA · direct butyrate supplementation amplifies effect. Advanced IBD/IBS stack, intestinal inflammaging.
D3 modulates tight junctions + GALT · omega-3 SPMs anti-inflammatory. Mucosal immunity + permeability combined probiotics stack.
8 real questions · answers based on ISAPP Sanders + Goldenberg + Mangell + Liu literature.
Supplements · treatments · biomarkers for your complete protocol.
My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.
Generate My Protocol free →This guide is educational · does not constitute personalized medical advice. Before supplementing, consult a healthcare professional. Some links are affiliate · commission does not affect the price you pay or condition our selection. No sponsorships. No advertorials.